The new Assisted Reproductive Technology (ART) regulations in India have had a significant impact on the cost of treatment and conception opportunities. Here are the recent changes and their effect: 1. Legalizing commercial surrogacy: The new regulations ban all commercial surrogacy, limiting it to only close relatives. This has led to a decrease in the availability of surrogate mothers, subsequently increasing their fees. 2. Age restriction for women: The regulations restrict women above the age of 50 from undergoing ART procedures, reducing the potential number of patients and limiting their chances of conception. 3. Embryo transfer limits: The new regulations restrict the number of embryo transfers per cycle, thus reducing the cost of treatment by preventing unnecessary procedures. 4. Mandatory insurance coverage: The regulations require clinics to provide insurance coverage for any adverse events during ART procedures. This has led to increased treatment costs as clinics pass on the insurance premiums to patients. Overall, the new regulations in India have had a mixed impact on the cost and availability of ART treatment, with some changes leading to increased costs and limited conception opportunities.